PRISM Mid-Day Movers: MedTech and New Energy are Today’s Leaders
bioAffinity Technologies (NASDAQ: BIAF) is up sharply again today, gaining roughly 56% intraday, following yesterday’s ~46% surge tied to news that CyPath® Lung will be positioned for post-treatment surveillance of lung cancer survivors — expanding the test’s commercial use beyond initial screening. The move is amplified by a smaller share float after BIAF’s recent 1-for-15 reverse split, which tends to magnify swings in thinly traded microcaps. The catalyst is genuine, but investors should weigh it against BIAF’s speculative, high-volatility profile and ongoing cash burn.
Montauk Renewables, Inc. (NASDAQ: MNTK) is up roughly 17% today, trading near $2.07 on volume well above its daily average — a notable pop for the landfill-methane-to-renewable-energy company, though no fresh company-specific catalyst has surfaced yet. The move comes after a stretch of pressure on the stock, including recent price-target cuts from several sell-side analysts even as Q2 2026 results showed revenue up nearly 20% year-over-year and a swing to positive net income. Investors should treat today’s rally with some caution given MNTK’s micro-cap size, thin average volume, and history of sharp single-day swings until a clearer driver emerges.
Other Notable Movers:
Ocuphire Pharma, Inc. (IRD) up 13%
FiscalNote (NOTE) up 13%
BioXcel Therapeutics, Inc. (BTAI) down -20%
Stock prices and percentage changes are as of 12:00 p.m. ET on September 2, 2026, and are subject to change.
